Tightrope walk between asthma phases: Visualizing asthma management

Asthma Flare-Up or Exacerbation? How to Tell the Difference and Get the Right Treatment

Jordan Keane monogram
Jordan Keane in Health & Wellness November 2026 • 5 min read.

"Understanding the nuances between worsening asthma and a full-blown exacerbation can help you take control of your respiratory health and prevent emergencies."


Asthma exacerbations are like unwelcome guests that can significantly impact your life, marking increased disease risk and the necessity for intensified therapy. The frequency of these exacerbations, especially those severe enough to require emergency room visits or hospitalization, serves as a key indicator of risk and a measure of how well your asthma treatment is working. When combined with symptom tracking and quality of life assessments, exacerbations become a focal point in determining the overall control of your asthma.

Preventing future flare-ups is a primary goal of asthma management. Asthma exacerbations also serve as a critical measure in asthma intervention studies. They represent significant risks to patients, causing anxiety, stress on healthcare systems, and potentially leading to chronic irreversible airflow obstruction. Given their major role, having a clear and consistent definition of what constitutes an asthma exacerbation is essential for effective treatment and improved outcomes.

While asthma exacerbations are often described as 'episodic flare-ups' that can be life-threatening and carry a substantial burden, defining them precisely has proven challenging. A recent expert group organized by the National Institutes of Health (NIH) suggested defining asthma exacerbations as a worsening of asthma symptoms requiring the use of oral corticosteroids to prevent a serious outcome.

AI Search Multiple angles on this topic

Asthma in the United States

CDC’s National Health Interview Survey data show that 8.7% of U.S. adults age 18 and older and 6.2% of children younger than 18 currently had asthma in 2022. The CDC also reports 4.9 million annual office visits for asthma. Its latest national and state tables draw on CDC surveillance systems and present asthma burden statistics for both children and adults.

Worsening Asthma vs. Exacerbation: Spotting the Key Differences

Tightrope walk between asthma phases: Visualizing asthma management

It is important to distinguish between poorly controlled asthma and a true exacerbation. Global Initiative for Asthma (GINA) includes symptoms like shortness of breath, wheezing, cough, and chest tightness as exacerbation criteria, along with a decline in lung function. However, this inclusion of symptoms can blur the lines between simply worsening asthma and a full-blown exacerbation.

A recent NIH expert panel highlighted the difficulty in distinguishing between poorly controlled asthma and an exacerbation, noting the vague and inconsistent terminology used. Many studies, and the GINA strategy, incorporate clinical symptoms - or increased short-acting beta-agonist (SABA) use - in their definitions of exacerbations. Research has demonstrated that increased SABA use typically precedes a defined exacerbation by a few days in both pediatric and adult asthmatics.

  • Increased frequency of symptoms such as wheezing, coughing, or shortness of breath.
  • A noticeable decrease in peak expiratory flow (PEF).
  • Greater reliance on rescue medications like albuterol.
  • Changes in lung function.
AI Search Multiple angles on this topic

Recent Research on Asthma Exacerbations

A 2025 review considers a “predict-and-prevent” approach: identifying patients at high risk, including those with type 2 inflammation, early and treating them aggressively to improve long-term asthma outcomes. A 2026 narrative review reports that recent guideline updates have not substantially changed acute exacerbation management. It describes early risk stratification, rapid severity assessment, inhaled bronchodilators, and systemic corticosteroids as the treatment cornerstones, with adjunctive therapies reserved for selected cases.

Mild Asthma Can Still Bring Severe Exacerbations

A systematic review cited in “The Myth of Mild” found that up to 22% of people with mild asthma had been hospitalized for asthma or experienced a severe exacerbation in the previous year. The article also reports severe exacerbation rates of 0.20 to 2.88 per year among patients using only short-acting β₂-agonist therapy. A separate best-practice advice source notes that exacerbations can occur at every asthma severity level despite guideline-directed treatment, and that a history of emergency department visits or hospitalization raises future exacerbation risk regardless of severity.

How Patients Use the Terms

A study of asthma terminology found that participants used “attack” for frightening events with major impacts on their lives. They used “exacerbation” and “flare-up” for both severe and mild, transient asthma-related events. Patients with severe asthma preferred the term “attack.” The terms therefore may carry different meanings for patients, even when they refer to asthma-related worsening.

According to a joint statement by the American Thoracic Society (ATS) and European Respiratory Society (ERS), asthma exacerbations should be stratified as either moderate or severe. They define severe exacerbations as 'events that require urgent action to prevent a serious outcome,' potentially involving systemic corticosteroid use or a visit to the hospital. Moderate exacerbations, on the other hand, were defined as ‘an event that, when recognized, should result in a temporary change in treatment, in an effort to prevent the exacerbation from becoming severe,’ and could include worsening symptoms or lung function, or increased bronchodilator use.

Take Control of Your Asthma: Prevention and Action

Recognizing the difference between worsening asthma and an exacerbation is crucial for effective management. The authors suggest that an increase in clinical symptoms and/or a need for reliever therapy indicates worsening asthma, presenting a window of opportunity for intervention.

AI Search Multiple angles on this topic

Tracking Trends and Future Risk

A repeated cross-sectional study evaluated population-level trends in asthma incidence and exacerbations to address evidence gaps and inform future public health strategies. A 2026 cohort study analyzed population-level changes in asthma exacerbations after respiratory biologics were rapidly approved in 2015. Another 2026 study indexed cohort entry to an asthma exacerbation, reflecting recognition of exacerbations as clinically meaningful events and focusing on a population enriched for future adverse outcomes.

Inflammation and Exacerbation Triggers

A 2024 review says asthma guidelines universally recommend inhaled corticosteroids as anti-inflammatory therapy for patients with persistent asthma symptoms, while noting that systemic inflammation has received limited attention. A 2023 chapter describes exacerbations as arising from an interplay of external exposures and host factors. It identifies respiratory viral infections—particularly rhinovirus—as dominant initiators, with allergens and other inhaled exposures as additional contributors.

Using symptom and reliever criteria in defining asthma worsening enables focused study of interventions. These may include adjusting the use of beta-agonists, inhaled corticosteroids, or adding other medications. This proactive approach aims to prevent progression to severe exacerbations.

By establishing a clear, standardized definition of asthma worsenings and exacerbations, healthcare professionals and patients can better navigate treatment plans and improve overall outcomes. Clear criteria, such as initiating systemic corticosteroids or needing emergency care, help distinguish exacerbations. A unified definition promotes more effective research and better care for all asthma patients.

How definitions and measures compare

A consensus definition specifies systemic corticosteroid use, or an increase from a stable maintenance dose, for at least three days as one qualifying criterion. Another harmonized definition describes an exacerbation as a change from usual status involving symptoms and reduced lung function sufficient to require a treatment change. These criteria make explicit why the article distinguishes a transient loss of control from an event that warrants a change in treatment.[1] [2]

A descriptive analysis of severe exacerbations reported a gradual PEF decline followed by faster changes, alongside rising symptoms and rescue beta-agonist use. Its severe-event definition included a prescribed oral corticosteroid course or a substantial PEF reduction on consecutive days, linking the observed pattern to an operational endpoint.[3]

The source material also includes a childhood trial designed to test whether increasing inhaled glucocorticoids prevents progression to exacerbation, and a separate report describing a cocaine-associated acute exacerbation. These illustrate different research questions and evidence types, rather than interchangeable definitions of worsening.[4] [5]

What remains unsettled about asthma worsening

  • How well do PEF trends observed in hospitalized children distinguish impending exacerbation from a transient loss of control in other patient groups?[1] [6]
  • Would seasonal patterns reported in this regional sample be similar in other settings, given the observed association between temperature and exacerbation?[7]

Sources

  1. ALAT-SEPAR Consensus on the Definition and Classification of Asthma Exacerbations by Severity: A Move Toward International Standardization☆ (pmc.ncbi.nlm.nih.gov)
  2. Harmonized Definitions for Asthma Outcome Measures - Standardized Library of Asthma Outcome Measures - NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube (www.ncbi.nlm.nih.gov)
  3. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. (pubmed.ncbi.nlm.nih.gov)
  4. Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations (PEDIATRICS, 2018)
  5. [Cocaine-induced asthma exacerbation]. (PubMed, 2022)
  6. USEFULNESS OF LONG TERM PEF MONIITORING IN ASTHMATIC CHILDREN (Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology, 1998)
  7. Influence of Seasonal Changes on Asthma Exacerbation in a Sudan Savanna Region (Annals of African Medicine, 2021)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.anai.2018.11.017, Alternate LINK

Title: Where Does Worsening Asthma End And An Asthma Exacerbation Begin?

Subject: Pulmonary and Respiratory Medicine

Journal: Annals of Allergy, Asthma & Immunology

Publisher: Elsevier BV

Authors: Elissa M. Abrams, Allan B. Becker, Stanley J. Szefler

Published: 2019-10-01

Everything You Need To Know

1

What is an Asthma exacerbation?

Asthma exacerbations, also known as 'episodic flare-ups,' represent a significant worsening of asthma symptoms. They are characterized by an increase in symptoms such as wheezing, coughing, or shortness of breath, along with a decline in lung function. These events often necessitate intensified therapy and can be life-threatening, highlighting their importance in asthma management. The National Institutes of Health (NIH) expert group suggests defining them as a worsening of asthma symptoms requiring the use of oral corticosteroids to prevent a serious outcome.

2

What is the difference between worsening asthma and an Asthma exacerbation?

Differentiating between worsening asthma and a true Asthma exacerbation is critical. Worsening asthma might involve increased symptoms or a greater need for reliever medications like albuterol. An Asthma exacerbation, however, often signifies a more severe event, potentially requiring urgent action, such as systemic corticosteroid use or a hospital visit. The Global Initiative for Asthma (GINA) criteria include shortness of breath, wheezing, cough, and chest tightness as exacerbation criteria, while increased short-acting beta-agonist (SABA) use typically precedes a defined exacerbation. The key is to recognize the opportunity for intervention when symptoms worsen to prevent an exacerbation.

3

What are the signs of an Asthma exacerbation?

Several factors help to identify an Asthma exacerbation. These include a noticeable decrease in peak expiratory flow (PEF), greater reliance on rescue medications like albuterol, and changes in lung function. The American Thoracic Society (ATS) and European Respiratory Society (ERS) stratify exacerbations into moderate and severe categories, with severe exacerbations requiring urgent action to prevent serious outcomes. Increased frequency of symptoms such as wheezing, coughing, or shortness of breath can also be a sign. The use of SABA, such as albuterol, will increase prior to a defined exacerbation.

4

Why are Asthma exacerbations important?

Asthma exacerbations are significant because they can greatly impact a person's life, increasing disease risk and the need for intensified therapy. The frequency of exacerbations is a key indicator of risk and how well asthma treatment is working. They can lead to anxiety, stress on healthcare systems, and potentially cause chronic, irreversible airflow obstruction. In asthma intervention studies, Asthma exacerbations also serve as a critical measure.

5

How are Asthma exacerbations managed?

The management of Asthma exacerbations involves immediate and long-term strategies. Recognizing the difference between worsening asthma and an exacerbation is the first step. For moderate exacerbations, treatment might involve temporary changes to prevent the condition from becoming severe. Severe exacerbations often require systemic corticosteroids. Long-term management focuses on preventing future flare-ups and maintaining overall asthma control. This involves regular symptom tracking, quality of life assessments, and adherence to a treatment plan.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.